|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer |
| 1. |
Maxim Pharmaceuticals, Inc.
|
|
|
Researches and develops therapy products and vaccines for the prevention and treatment of tumors and leukema. Based in San Diego, California. (Nasdaq: MAXM)
|
| 2. |
Onyvax Ltd.
|
|
|
Conducts research and development for marketing cell-based vaccines and human monoclonal antibody against CD55 in tumour cells. Includes explanation of products in pipeline, and clinical studies in phase II of prostate cancer vaccine at Bournemouth, and their contacts in London, UK.
|
| 3. |
PNP Therapeutics, Inc.
|
|
|
Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama.
|
| 4. |
Australian Cancer Technology Pty Ltd
|
|
|
Company developing three approaches for cures; Chk1 kinase inhibitor, mutated p53 gene and retroviral display vaccines. Includes announcements, media releases, overview of projects incollaboration with UK, a hospital in Sydney, and corporate details at West Perth, Western Australia.
|
| 5. |
Igeneon
|
|
|
Developing vaccines and monoclonal antibodies to delay formation of metastases of epithelial origin. Includes progress of clinical trials and invetor data for company in Vienna, Austria.
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
